{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:54:40Z","timestamp":1791644080966,"version":"4.3.4"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Lifelong premature ejaculation (PE) in men lacks an adequate on-demand pharmacological treatment. Although selective serotonin reuptake inhibitors (SSRIs) are used for PE they only work after chronic treatment, or if used on-demand, less adequately than chronic SSRI treatment. It has been shown that the addition of a behaviorally silent 5-HT<jats:sub>1A<\/jats:sub>\u2013receptor antagonist to an SSRI can generate acute inhibitory effects on male rat sexual behavior. Atlas987 is a selective 5-HT<jats:sub>1A<\/jats:sub>-receptor antagonist with equal potency to displace agonist and antagonist binding to pre- and post-synaptic 5-HT<jats:sub>1A<\/jats:sub> receptors in rat and human brain. To investigate whether Atlas987 together with the SSRI paroxetine, a combination called Enduro, induces acute inhibitory effects on male rat sexual behavior, we tested Enduro in Wistar rats in a dose-dependent manner. We first tested the 5-HT<jats:sub>1A<\/jats:sub> receptor antagonist Atlas987 in 8-OH-DPAT induced serotonergic behavior in rats. Second, we tested Enduro in a dose-dependent manner in male sexual behavior. Third, we tested the effective time window of Enduro\u2019s action, and lastly, we measured the plasma levels of Atlas987 and paroxetine over an 8-h period. Results showed that Enduro acutely and dose-dependently reduced the number of ejaculations and increased the ejaculation latencies. The behavioral pattern induced reflected a specific effect on sexual behavior excluding non-specific effects like sedation or sensoric-motoric disturbances. The time-window of activity of Enduro showed that this sexual inhibitory activity was at least found in a 1\u20134\u2009h\u2019 time window after administration. Plasma levels showed that in this time frame both Atlas987 and paroxetine are present. In conclusion, in rats, Enduro is successful in acutely inhibiting sexual behavior. These results may be therapeutically attractive as \u201con demand\u201d treatment for life-long premature ejaculation in men.<\/jats:p>","DOI":"10.3389\/fnins.2023.1224959","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:51:26Z","timestamp":1694649086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A new approach to \u2018on-demand\u2019 treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT1A receptor antagonist and SSRI in rats"],"prefix":"10.3389","volume":"17","author":[{"given":"Jocelien D. A.","family":"Olivier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josien A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Esquivel-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"de Pr\u00eatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/sj.bjp.0702206","article-title":"A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat","volume":"125","author":"Adell","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0014-2999(99)00483-5","article-title":"Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior","volume":"379","author":"Ahlenius","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref3","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5\u2122","year":"2013"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.euroneuro.2017.10.032","article-title":"Can we increase speed and efficacy of antidepressant treatments? Part I: general aspects and monoamine-based strategies","volume":"28","author":"Artigas","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/pr.118.015552","article-title":"International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function","volume":"73","author":"Barnes","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-2999(90)90344-6","article-title":"Antagonism of 8-OH-DPAT-induced behaviour in rats","volume":"187","author":"Berendsen","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/0091-3057(89)90477-2","article-title":"Selective activation of 5-HT1A receptors induces lower lip retraction in the rat","volume":"33","author":"Berendsen","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ejphar.2007.11.028","article-title":"Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?","volume":"580","author":"Beyer","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fnbeh.2019.00257","article-title":"The sexual motivation of male rats as a tool in animal models of human health disorders","volume":"13","author":"Bialy","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pbb.2013.10.004","article-title":"Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?","volume":"121","author":"Bijlsma","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.sxmr.2019.03.003","article-title":"Topical agents for premature ejaculation: a review","volume":"8","author":"Butcher","year":"2020","journal-title":"Sex Med Rev."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ejphar.2008.02.098","article-title":"Translational research into sexual disorders: pharmacology and genomics","volume":"585","author":"Chan","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1743-6109.2010.01961.x","article-title":"The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats","volume":"8","author":"Chan","year":"2011","journal-title":"J. Sex. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.esxm.2019.06.001","article-title":"Interventions to treat erectile dysfunction and premature ejaculation: an overview of systematic reviews","volume":"7","author":"Ciocanel","year":"2019","journal-title":"Sex Med."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejphar.2004.12.024","article-title":"Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivity","volume":"509","author":"de Jong","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neubiorev.2006.01.001","article-title":"Serotonin and the neurobiology of the ejaculatory threshold","volume":"30","author":"de Jong","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.12659\/MSM.913606","article-title":"Efficacy and safety of \"on-demand\" Dapoxetine in treatment of patients with premature ejaculation: a Meta-analysis","volume":"25","author":"Du","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnbeh.2020.00040","article-title":"Pharmacological studies on the role of 5-HT1A receptors in male sexual behavior of wildtype and serotonin transporter knockout rats","volume":"14","author":"Esquivel-Franco","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3389\/fphar.2018.00676","article-title":"Tramadol's inhibitory effects on sexual behavior: pharmacological studies in serotonin transporter knockout rats","volume":"9","author":"Esquivel-Franco","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0893-133X(99)00125-6","article-title":"PET-determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brain","volume":"22","author":"Farde","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0014-2999(93)90280-u","article-title":"WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors","volume":"237","author":"Fletcher","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0024-3205(94)00876-0","article-title":"Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis","volume":"55","author":"Fuller","year":"1994","journal-title":"Life Sci."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1472-8206.1996.tb00145.x","article-title":"Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies","volume":"10","author":"Gardier","year":"1996","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/j.1476-5381.1995.tb15919.x","article-title":"Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT","volume":"115","author":"Gartside","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0014-2999(00)00723-8","article-title":"Effect of a selective5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine","volume":"407","author":"Haj\u00f3s-Korcsok","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbr.2017.10.029","article-title":"Assessment of sexual behavior in rats: the potentials and pitfalls","volume":"352","author":"Heijkoop","year":"2018","journal-title":"Behav. Brain Res."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1177\/0269881116647621","article-title":"Looking back (and in)to the future: a personal reflection on 'Serotonin autoreceptor function and antidepressant drug action' (Hjorth et al., 2000)","volume":"30","author":"Hjorth","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/026988110001400208","article-title":"Serotonin autoreceptor function and antidepressant drug action","volume":"14","author":"Hjorth","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"104458","DOI":"10.1016\/j.beproc.2021.104458","article-title":"Male rat sexual behavior: insights from inter-copulatory intervals","volume":"190","author":"Huijgens","year":"2021","journal-title":"Behav. Process."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/11598150-000000000-00000","article-title":"A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation","volume":"35","author":"Hutchinson","year":"2012","journal-title":"Drug Saf."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ijir.2014.37","article-title":"Antidepressant treatment of premature ejaculation: discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting","volume":"27","author":"Jern","year":"2015","journal-title":"Int. J. Impot. Res."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.euroneuro.2015.12.039","article-title":"The 5-HT1A receptor in major depressive disorder","volume":"26","author":"Kaufman","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1517\/13543776.2012.703654","article-title":"The therapeutic potential of 5-HT1A receptors: a patent review","volume":"22","author":"Lacivita","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.pbb.2005.09.014","article-title":"Differential effects of simultaneous or sequential administration of paroxetine and WAY-100,635 on ejaculatory behavior","volume":"82","author":"Looney","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1071\/SH15042","article-title":"Topical anaesthetics for premature ejaculation: a systematic review and meta-analysis","volume":"13","author":"Martyn-St James","year":"2016","journal-title":"Sex. Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/smrj.49","article-title":"Current and emerging treatments for premature ejaculation","volume":"3","author":"McMahon","year":"2015","journal-title":"Sex Med Rev."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jsxm.2020.09.012.-53","article-title":"A double-blind, placebo-controlled parallel group study to evaluate the effect of a single Oral dose of 5-HT1A antagonist GSK958108 on ejaculation latency time in male patients suffering from premature ejaculation","volume":"18","author":"Migliorini","year":"2021","journal-title":"J. Sex. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.urology.2013.05.018","article-title":"Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a \"Waterloo\"","volume":"82","author":"Mondaini","year":"2013","journal-title":"Urology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00210-001-0497-7","article-title":"Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex","volume":"365","author":"Nakayama","year":"2002","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1038\/sj.ijir.3901330","article-title":"Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions?","volume":"18","author":"Olivier","year":"2006","journal-title":"Int. J. Impot. Res."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuropharm.2016.11.020","article-title":"Tramadol: effects on sexual behavior in male rats are mainly caused by its 5-HT reuptake blocking effects","volume":"116","author":"Olivier","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-1-0716-2083-0_20","article-title":"Antidepressants, sexual behavior, and translational models for male sexual dysfunction: development of animal models, pharmacology and genetics","volume-title":"Translational research methods for major depressive disorder","author":"Olivier","year":"2022"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-0348-8730-4_3","article-title":"The 5-HT1A receptor and its ligands: structure and function","volume":"52","author":"Olivier","year":"1999","journal-title":"Prog. Drug Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.esxm.2017.02.003","article-title":"Discontinuation of dapoxetine treatment in patients with premature ejaculation: a 2-year prospective observational study","volume":"5","author":"Park","year":"2017","journal-title":"Sex Med."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1460-9568.2005.04252.x","article-title":"Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders","volume":"22","author":"Pattij","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.sxmr.2018.05.001","article-title":"Novel treatment for premature ejaculation in the light of currently used therapies: a review","volume":"7","author":"Porst","year":"2019","journal-title":"Sex Med Rev."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1021\/js970253z","article-title":"Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis","volume":"86","author":"Ramaiya","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1046\/j.1471-4159.1997.68062593.x","article-title":"Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors","volume":"68","author":"Romero","year":"1997","journal-title":"J. Neurochem."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1476-5381.2011.01770.x","article-title":"Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment","volume":"167","author":"Scorza","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pbb.2013.11.003","article-title":"Antidepressant-induced sexual dysfunction in men","volume":"121","author":"Segraves","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"108155","DOI":"10.1016\/j.neuropharm.2020.108155","article-title":"Central 5-HT receptors and their function; present and future","volume":"177","author":"Sharp","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0165-0270(90)90045-h","article-title":"Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor","volume":"34","author":"Sharp","year":"1990","journal-title":"J. Neurosci. Methods"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/sj.bjp.0701235","article-title":"Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo","volume":"121","author":"Sharp","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pbb.2013.11.007","article-title":"Serotonin 1A receptors and sexual behavior in male rats: a review","volume":"121","author":"Snoeren","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/s0960-894x(98)00406-5","article-title":"Functional characteristics of a series of N4-substituted 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazines as 5-HT1A receptor ligands. Structure-activity relationships","volume":"8","author":"van Steen","year":"1998","journal-title":"Bioorg Med Chem Lett."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1097\/01.ju.0000035599.35887.8f","article-title":"The neurobiological approach to premature ejaculation","volume":"168","author":"Waldinger","year":"2002","journal-title":"J. Urol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/YCO.0000000000000096","article-title":"Pharmacotherapy for premature ejaculation","volume":"27","author":"Waldinger","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14656566.2018.1494725","article-title":"Drug treatment options for premature ejaculation","volume":"19","author":"Waldinger","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0166-4328(97)00183-6","article-title":"Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system","volume":"92","author":"Waldinger","year":"","journal-title":"Behav. Brain Res."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1176\/ajp.151.9.1377","article-title":"Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study","volume":"151","author":"Waldinger","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1046\/j.1464-410x.1997.00102.x","article-title":"Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study","volume":"79","author":"Waldinger","year":"1997","journal-title":"Br. J. Urol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/00004714-199808000-00004","article-title":"Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline","volume":"18","author":"Waldinger","year":"","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0140-6736(06)69773-0","article-title":"Dapoxetine treatment of premature ejaculation","volume":"368","author":"Waldinger","year":"2006","journal-title":"Lancet"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00004714-200106000-00007","article-title":"Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone","volume":"21","author":"Waldinger","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.urology.2015.01.009","article-title":"Efficacy of Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized clinical trials on intravaginal ejaculatory latency time, patient-reported outcomes, and adverse events","volume":"85","author":"Yue","year":"2015","journal-title":"Urology"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1224959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:51:29Z","timestamp":1694649089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1224959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":65,"alternative-id":["10.3389\/fnins.2023.1224959"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1224959","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"article-number":"1224959"}}